[1] |
Kalantari M, Deyhimi P, Kalantari P. Peripheral Primitive Neuroectodermal Tumor (pPNET) of the Parotid: Report of a Rare Case[J]. Arch Iran Med, 2015, 18(12):858-860.
doi: 0151812/AIM.0012
pmid: 26621020
|
[2] |
Woeste MR, Bhutiani N, Hong YK, et al. Primitive neuroectodermal tumor incidence, treatment patterns, and outcome: An analysis of the National Cancer Database[J]. J Surg Oncol, 2020, 122(6):1145-1151. doi: 10.1002/jso.26139.
doi: 10.1002/jso.26139
URL
|
[3] |
Matsuo M, Saigo C, Takeuchi T, et al. Ovarian Clear Cell Carcinoma and Mature Cystic Teratoma Transformed to PNET and Carcinosarcoma: A Case Report with an Immunohistochemical Investigation[J]. Biomedicines, 2022, 10(3):547. doi: 10.3390/biomedicines10030547.
doi: 10.3390/biomedicines10030547
URL
|
[4] |
Chao X, Bi Y, Li L. Ovarian primary primitive neuroectodermal tumor: a review of cases at PUMCH and in the published literature[J]. Orphanet J Rare Dis, 2019, 14(1):147. doi: 10.1186/s13023-019-1106-5.
doi: 10.1186/s13023-019-1106-5
pmid: 31217017
|
[5] |
Sheikhhasani S, Saffar H, Zamani N, et al. Primitive Neuroectodermal Tumor of the Ovary: A Case Report[J]. J Obstet Gynecol Cancer Res, 2022, 7(3):251-253. doi: 10.30699/jogcr.7.3.251.
doi: 10.30699/jogcr.7.3.251
URL
|
[6] |
Gao L, Zhu Y, Shi X, et al. Peripheral primitive neuroectodermal tumors: A retrospective analysis of 89 cases and literature review[J]. Oncol Lett, 2019, 18(6):6885-6890. doi: 10.3892/ol.2019.11011.
doi: 10.3892/ol.2019.11011
pmid: 31788128
|
[7] |
Liu J, Zhao YL, Song SQ, et al. Primitive neuroectodermal tumors: a clinical and radiological analysis of six cases[J]. Quant Imaging Med Surg, 2019, 9(4):722-729. doi: 10.21037/qims.2019.03.16.
doi: 10.21037/qims.2019.03.16
URL
|
[8] |
Tsokos M, Alaggio RD, Dehner LP, et al. Ewing sarcoma/peripheral primitive neuroectodermal tumor and related tumors[J]. Pediatr Dev Pathol, 2012, 15(< W>1 Suppl):108-126. doi: 10.2350/11-08-1078-PB.1.
doi: 10.2350/11-08-1078-PB.1
URL
|
[9] |
Tintila A, Doroftei B, Grab D, et al. Importance of studying primitive neuroectodermal tumors and extraosseous Ewings sarcoma of the vagina and vulva[J]. Oncol Lett, 2021, 21(2):171. doi: 10.3892/ol.2021.12432.
doi: 10.3892/ol.2021.12432
pmid: 33552288
|
[10] |
Theisen ER, Pishas KI, Saund RS, et al. Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting[J]. Oncotarget, 2016, 7(14):17616-17630. doi: 10.18632/oncotarget.7124.
doi: 10.18632/oncotarget.7124
pmid: 26848860
|
[11] |
Snyder BM, Lion AH, Helvie AE, et al. Targeted treatment of refractory primitive neuroectodermal tumor arising from an immature teratoma with crizotinib leading to a sustained response[J]. Clin Case Rep, 2023, 11(1):e6779. doi: 10.1002/ccr3.6779.
doi: 10.1002/ccr3.6779
URL
|
[12] |
Lins RS, Pereira ES, Romeiro TA, et al. Primitive Neuroectodermal Tumor (PNET) of the Endometrium[J]. IJGO, 2019, 17:81. doi:10.1007/s40944-019-0325-y.
doi: 10.1007/s40944-019-0325-y
|
[13] |
Bachert SE, Baldwin LA, Dueber JC, et al. Ovarian Primitive Neuroectodermal Tumor: Are You Central or Peripheral?[J]. Int J Gynecol Pathol, 2022, 41(2):203-205. doi: 10.1097/PGP.0000000000000789.
doi: 10.1097/PGP.0000000000000789
URL
|
[14] |
Wexler LH, DeLaney TF, Tsokos M, et al. Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing′s sarcoma family of tumors[J]. Cancer, 1996, 78(4):901-911. doi: 10.1002/(SICI)1097-0142(19960815)78:4<901::AID-CNCR30>3.0.CO;2-X.
doi: 10.1002/(SICI)1097-0142(19960815)78:4<901::AID-CNCR30>3.0.CO;2-X
pmid: 8756388
|
[15] |
钞晓培, 谭先杰. 卵巢原发原始神经外胚层肿瘤诊治进展[J]. 现代妇产科进展, 2018, 27(2):139-141. doi: 10.13283/j.cnki.xdfckjz.2018.02.030.
doi: 10.13283/j.cnki.xdfckjz.2018.02.030
|
[16] |
Takigami A, Yamasawa H, Kurosaki A, et al. Pazopanib Confers a Progression-free Survival in a Patient with Ewing′s Sarcoma/Primitive Neuroectodermal Tumor of the Lung[J]. Intern Med, 2019, 58(9):1335-1339. doi: 10.2169/internalmedicine.1549-18.
doi: 10.2169/internalmedicine.1549-18
URL
|
[17] |
Garcia-Moure M, Martinez-Velez N, Gonzalez-Huarriz M, et al. The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models[J]. Sci Rep, 2019, 9(1):14368. doi: 10.1038/s41598-019-51014-1.
doi: 10.1038/s41598-019-51014-1
pmid: 31591461
|
[18] |
Priya D, Kumar RV, Appaji L, et al. Histological diversity and clinical characteristics of Ewing sarcoma family of tumors in children: A series from a tertiary care center in South India[J]. Indian J Cancer, 2015, 52(3):331-335. doi: 10.4103/0019-509X.176700.
doi: 10.4103/0019-509X.176700
pmid: 26905130
|